Atlas Trials

DLL3-Targeted PET/CT in Neuroendocrine Carcinoma

Clinical trial NCT07458906 · RECRUITING

Trial details

NCT number
NCT07458906
Sponsor
The First Affiliated Hospital of Xiamen University
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
DLL3-expressing TumorsPET / CTNeuroendocrine Cancer
Start date
2025-12-01
Primary completion
2026-12-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.